SCHEMBL5237367

SCHEMBL5237367

C=CCc1c(OCc2ccccc2)cc(O)c2c(=O)c3cccc(OCc4ccccc4)c3oc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.45
MAOA P21397 4/20 0.41
IKBKB O14920 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
POLB P06746 1/20 0.40
MAOB P27338 2/20 0.39
NUDT1 P36639 1/20 0.38
RELA Q04206 1/20 0.38
PTPN1 P18031 1/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
GSK3B P49841 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
ABCB1 P08183 1/20 0.37
MAPT P10636 1/20 0.37
ATP1A1 P05023 1/20 0.37
ATP1B1 P05026 1/20 0.37
ATP1A3 P13637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6281277 0.87 LOXL2 (0.44) LOXL2MAOA
SCHEMBL5236219 0.75 MAOA (0.64) MAOAIKBKBACHEMAOBNUDT1
SCHEMBL11096994 0.72 SRD5A1 (0.49) MAOAPOLBMAOBMAPT
SCHEMBL10689679 0.71 HTR1A (0.48) PTPN1CDK1CCNB1MAPT
SCHEMBL5349187 0.70 MAOA (0.76) MAOAACHEPOLBMAOBABCB1
SCHEMBL5239013 0.69 LOXL2 (0.47) LOXL2MAOAMAPT
SCHEMBL4238441 0.68 CYP2C19 (0.42) MAOBRELAPTPN1CDK1CCNB1
SCHEMBL7172523 0.67 HTR1A (0.46) BCHEABCB1MAPT
SCHEMBL7561778 0.67 CYP2C19 (0.41) RELAPTPN1MAPT
SCHEMBL7546749 0.66 BCHE (0.60) MAOABCHEACHEMAOBABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585740-A4 PROCESS TO PREPARE PSOROSPERMIN CYLENE PHARMACEUTICALS INC (US) 2007-06-13 EP disclosed
EP-1585740-A2 PROCESS TO PREPARE PSOROSPERMIN Cylene Pharmaceuticals, Inc. (US) 2005-10-19 EP disclosed
US-6933396-B2 Process to prepare psorospermin CYLENE PHARMACEUTICALS (US) 2005-08-23 US disclosed
US-20040102515-A1 Process to prepare psorospermin CYLENE PHARMACEUTICALS 2004-05-27 US disclosed
WO-2004019888-A2 PROCESS TO PREPARE PSOROSPERMIN CYLENE PHARMACEUTICALS, INC. (US) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102515-A1 Process to prepare psorospermin BPGM, DHPS, FDPS LOXL2 3973/4885MAOA 761/4885IKBKB 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.